Comparison of commercially available immunoblot assays measuring IgG and IgA antibodies to Bordetella pertussis antigens

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 30, Issue 12, 2011, Pages 1531-1535

  Kennerknecht, N ^a,b   Riffelmann, M ^a,b   Schmetz, J ^b   Wirsing Von Konig C H ^a,b  

^a Labor:Medizin Krefeld Medizinisches Versorgungszentrum   (Germany)

^b HELIOS KLINIKUM KREFELD   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE CYCLASE TOXIN; BACTERIAL ANTIGEN; BORDETELLA PERTUSSIS ANTIGEN; DIPHTHERIA PERTUSSIS TETANUS VACCINE; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; PERTUSSIS TOXIN; TDAP; UNCLASSIFIED DRUG;

ALGORITHM; ANTIBODY DETECTION; ANTIBODY TITER; ANTIGEN ANTIBODY REACTION; ARTICLE; BLOOD ANALYSIS; BORDETELLA PERTUSSIS; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DIAGNOSTIC KIT; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; FOOD AND DRUG ADMINISTRATION; HUMAN; IMMUNOBLOTTING; NATIONAL HEALTH ORGANIZATION; PERTUSSIS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REFERENCE VALUE; SENSITIVITY AND SPECIFICITY; SERODIAGNOSIS; SYMPTOM; VACCINATION; WORLD HEALTH ORGANIZATION;

EID: 85027921865     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/s10096-011-1256-4     Document Type: Article

References (17)

1. S Mattoo JD Cherry 2005 Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies Clin Microbiol Rev 18 326 382 15831828 10.1128/CMR.18.2.326-382.2005 1:CAS:528:DC%2BD2MXksVymtbs%3D (Pubitemid 40548297)
2. SC Redd HS Rumschlag RJ Biellik GN Sanden CB Reimer ML Cohen 1988 Immunoblot analysis of humoral immune responses following infection with Bordetella pertussis or immunization with diphtheria-tetanus-pertussis vaccine J Clin Microbiol 26 1373 1377 2900846 1:STN:280:DyaL1czhsFejsQ%3D%3D
3. N Guiso E Grimprel I Anjak P Bégué 1993 Western blot analysis of antibody responses of young infants to pertussis infection Eur J Clin Microbiol Infect Dis 12 596 600 8223658 10.1007/BF01973637 1:STN:280:DyaK2c%2FjvFWmuw%3D%3D (Pubitemid 23268227)
4. E Grimprel P Bégué I Anjak E Njamkepo P François N Guiso 1996 Long-term human serum antibody responses after immunization with whole-cell pertussis vaccine in France Clin Diagn Lab Immunol 3 93 97 8770511 1:STN:280:DyaK28zms1egtg%3D%3D (Pubitemid 26040690)
5. Directive 98/79/EC of the European Parliament and of the Council of 27 October 1998 on in vitro diagnostic medical devices (1998) Available online at: http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=CELEX:31998L0079:EN:HTML, accessed 20th November 2010
6. M Watanabe B Connelly AA Weiss 2006 Characterization of serological responses to pertussis Clin Vaccine Immunol 13 341 348 16522775 10.1128/CVI.13.3.341-348.2006 1:CAS:528:DC%2BD28XjsVKjsr4%3D
7. N Guiso G Berbers NK Fry Q He M Riffelmann CH Wirsing von König EU Pertstrain group 2011 What to do and what not to do in serological diagnosis of pertussis: recommendations from EU reference laboratories Eur J Clin Microbiol Infect Dis 30 307 312 21069406 10.1007/s10096-010-1104-y 1:STN:280: DC%2BC3M7ntlWruw%3D%3D
8. D Xing CH Wirsing von König P Newland M Riffelmann BD Meade M Corbel R Gaines-Das 2009 Characterization of reference materials for human antiserum to pertussis antigens by an international collaborative study Clin Vaccine Immunology 16 303 311 10.1128/CVI.00372-08 1:CAS:528:DC%2BD1MXlsFyjtL0%3D
9. CH Wirsing von König D Gounis S Laukamp H Bogaerts HJ Schmitt 1999 Evaluation of a single-sample serological technique for diagnosing pertussis in unvaccinated children Eur J Clin Microbiol Infect Dis 18 341 345 10421041 10.1007/PL00015016 (Pubitemid 29531170)
10. JL Arciniega EL Hewlett FD Johnson A Deforest SG Wassilak IM Onorato CR Manclark DL Burns 1991 Human serologic response to envelope-associated proteins and adenylate cyclase toxin of Bordetella pertussis J Infect Dis 163 135 142 1984460 10.1093/infdis/163.1.135 1:STN:280:DyaK3M%2FnvFKgug%3D%3D
11. ML Tondella GM Carlone N Messonnier CP Quinn BD Meade DL Burns JD Cherry N Guiso EL Hewlett KM Edwards D Xing A Giammanco CH Wirsing von König L Han L Hueston JB Robbins M Powell CM Mink JT Poolman SW Hildreth F Lynn A Morris 2009 International Bordetella pertussis assay standardization and harmonization meeting report. Centers for Disease Control and Prevention, Atlanta, Georgia, United States, 19-20 July 2007 Vaccine 27 803 814 19071179 10.1016/j.vaccine. 2008.11.072 1:STN:280:DC%2BD1M%2FptlKmsA%3D%3D
12. RG Pebody NJ Gay A Giammanco S Baron J Schellekens A Tischer RM Olander NJ Andrews WJ Edmunds H Lecoeur D Lévy-Bruhl PA Maple H de Melker A Nardone MC Rota S Salmaso MA Conyn-van Spaendonck S Swidsinski E Miller 2005 The seroepidemiology of Bordetella pertussis infection in Western Europe Epidemiol Infect 133 159 171 15724723 10.1017/S0950268804003012 1:STN:280: DC%2BD2M%2FpsVGrtQ%3D%3D (Pubitemid 40276986)
13. HE de Melker FG Versteegh MA Conyn-van Spaendonck LH Elvers GA Berbers A van der Zee JF Schellekens 2000 Specificity and sensitivity of high levels of immunoglobulin G antibodies against pertussis toxin in a single serum sample for diagnosis of infection with Bordetella pertussis J Clin Microbiol 38 800 806 10655388 (Pubitemid 30082684)
14. AL Baughman KM Bisgard KM Edwards D Guris MD Decker K Holland BD Meade F Lynn 2004 Establishment of diagnostic cutoff points for levels of serum antibodies to pertussis toxin, filamentous hemagglutinin, and fimbriae in adolescents and adults in the United States Clin Diagn Lab Immunol 11 1045 1053 15539504 1:CAS:528:DC%2BD2cXhtFShsr3L (Pubitemid 39540842)
15. FG Versteegh PL Mertens HE de Melker JJ Roord JF Schellekens PF Teunis 2005 Age-specific long-term course of IgG antibodies to pertussis toxin after symptomatic infection with Bordetella pertussis Epidemiol Infect 133 737 748 16050521 10.1017/S0950268805003833 1:CAS:528:DC%2BD2MXlsF2hs7Y%3D (Pubitemid 41015566)
16. JI Ward JD Cherry SJ Chang S Partridge W Keitel K Edwards M Lee J Treanor DP Greenberg S Barenkamp DI Bernstein R Edelman APERT Study Group 2006 Bordetella pertussis infections in vaccinated and unvaccinated adolescents and adults, as assessed in a national prospective randomized Acellular Pertussis Vaccine Trial (APERT) Clin Infect Dis 43 151 157 16779740 10.1086/504803
17. JD Cherry DX Xing P Newland K Patel U Heininger MJ Corbel 2004 Determination of serum antibody to Bordetella pertussis adenylate cyclase toxin in vaccinated and unvaccinated children and in children and adults with pertussis Clin Infect Dis 38 502 507 14765342 10.1086/381204 1:CAS:528:DC%2BD2cXitlyltbk%3D (Pubitemid 38250959)